Last updated: 2026-09-16 10:31:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Simulations Plus, Inc. (SLP) operates in the SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN sector and is listed on NASDAQ. The stock is currently priced at $18.41, with a market capitalisation of $372.54M and a P/E ratio of 45.94. Over the past 52 weeks, its price has ranged from $11.09 to $21.01. This page covers its latest market performance, valuation, price trends and company information.
$372.54M | |
$18.42 | |
$90.92 | |
$0.01 | |
$18.42 | |
105.54K | |
416.40K | |
45.94 | |
$21.01 | |
$11.09 | |
-- | |
-- |
Simulations Plus, Inc. (SLP) is trading at $18.43 in pre-market trading as of 2026-09-15 23:31:00, up 0.03% ($0.00) from the previous close of $18.42
Pre-market trading shows how investors are pricing SLP before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Simulations Plus, Inc. (SLP) moved from $18.43 to $18.41, representing a decline of 0.14% ($0.02).
The stock traded between $18.40 and $18.45 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.
The average daily volume was 157.73 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 73.7%
SLP is currently trading at $18.41, placing it 73.7% of the way from its 52-week low of $11.09 to its 52-week high of $21.01. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
| Industry | SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN |
| Employees | 213 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Simulations Plus, Inc. (SLP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.